NOVAVAX - RECENT DATA FROM PHASE 2 TRIAL LEAD US TO BELIEVE THAT OUR VACCINE IS LIKELY TO PROVIDE PROTECTION AGAINST NEW, EMERGING COVID-19 VARIANTS